ScinoPharm Taiwan Ltd (1789) – Strategy, SWOT and Corporate Finance Report

ScinoPharm Taiwan Ltd (1789) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

ScinoPharm Taiwan Ltd (ScinoPharm) provides process research and development and active pharmaceutical ingredient manufacturing services to the pharmaceutical industry. The services include custom synthesis for early phase pharmaceutical activities, brand companies and APIs for the generic industry, among others. The company also provides contract research and manufacturing services (CRAM) services and chemistry skill, analytical and regulatory services, chemical process development, clinical drug substances, exploratory process research and consulting services. The company has research and manufacturing facilities in Taiwan and China. ScinoPharm is headquartered in Tainan, Taiwan

Scope

• Detailed information on ScinoPharm Taiwan Ltd required for business and competitor intelligence needs

• A study of the major internal and external factors affecting ScinoPharm Taiwan Ltd in the form of a SWOT analysis

• An in-depth view of the business model of ScinoPharm Taiwan Ltd including a breakdown and examination of key business segments

• News about ScinoPharm Taiwan Ltd, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of ScinoPharm Taiwan Ltd and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess ScinoPharm Taiwan Ltd as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on ScinoPharm Taiwan Ltds business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Zhejiang Huahai Pharmaceutical Co Ltd

SCI Pharmtech Inc

Savior Lifetec Corp

Synmosa Biopharma Corp

Teva Pharmaceutical Industries Ltd

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

ScinoPharm Taiwan Ltd - Key Facts

ScinoPharm Taiwan Ltd - Key Employees

ScinoPharm Taiwan Ltd - Key Employee Biographies

ScinoPharm Taiwan Ltd - Major Products and Services

ScinoPharm Taiwan Ltd - History

ScinoPharm Taiwan Ltd - Company Statement

ScinoPharm Taiwan Ltd - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Joint Venture

Section 2 – Company Analysis

Company Overview

ScinoPharm Taiwan Ltd - Business Description

Business Segment: API

Overview

Performance

Business Segment: Injection Products

Performance

Business Segment: Others

Performance

Business Segment: Technical Services

Performance

Geographical Segment: Asia

Performance

Geographical Segment: Europe

Performance

Geographical Segment: India

Performance

Geographical Segment: Others

Performance

Geographical Segment: Taiwan

Performance

Geographical Segment: The USA

Performance

R&D Overview

ScinoPharm Taiwan Ltd - Corporate Strategy

ScinoPharm Taiwan Ltd - SWOT Analysis

SWOT Analysis - Overview

ScinoPharm Taiwan Ltd - Strengths

ScinoPharm Taiwan Ltd - Weaknesses

ScinoPharm Taiwan Ltd - Opportunities

ScinoPharm Taiwan Ltd - Threats

ScinoPharm Taiwan Ltd - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

ScinoPharm Taiwan Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

ScinoPharm Taiwan Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023

ScinoPharm Taiwan Ltd, Recent Deals Summary

Section 5 – Company’s Recent Developments

Dec 30, 2022: ScinoPharm’s Injectable and API Plants Pass FDA’s pre-approval on-site inspections

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

ScinoPharm Taiwan Ltd, Key Facts

ScinoPharm Taiwan Ltd, Key Employees

ScinoPharm Taiwan Ltd, Key Employee Biographies

ScinoPharm Taiwan Ltd, Major Products and Services

ScinoPharm Taiwan Ltd, History

ScinoPharm Taiwan Ltd, Other Locations

ScinoPharm Taiwan Ltd, Subsidiaries

ScinoPharm Taiwan Ltd, Joint Venture

ScinoPharm Taiwan Ltd, Key Competitors

ScinoPharm Taiwan Ltd, Ratios based on current share price

ScinoPharm Taiwan Ltd, Annual Ratios

ScinoPharm Taiwan Ltd, Annual Ratios (Cont…1)

ScinoPharm Taiwan Ltd, Annual Ratios (Cont…2)

ScinoPharm Taiwan Ltd, Interim Ratios

ScinoPharm Taiwan Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

ScinoPharm Taiwan Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023

ScinoPharm Taiwan Ltd, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

ScinoPharm Taiwan Ltd, Performance Chart (2018 – 2022)

ScinoPharm Taiwan Ltd, Ratio Charts

ScinoPharm Taiwan Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

ScinoPharm Taiwan Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports